197 related articles for article (PubMed ID: 30487999)
1. DAPSA and ultrasound show different perspectives of psoriatic arthritis disease activity: results from a 12-month longitudinal observational study in patients starting treatment with biological disease-modifying antirheumatic drugs.
Pukšić S; Bolton-King P; Sexton J; Michelsen B; Kvien TK; Berner Hammer H
RMD Open; 2018; 4(2):e000765. PubMed ID: 30487999
[TBL] [Abstract][Full Text] [Related]
2. Ultrasonographic evaluation in psoriatic arthritis is of major importance in evaluating disease activity.
Michelsen B; Diamantopoulos AP; Hammer HB; Soldal DM; Kavanaugh A; Haugeberg G
Ann Rheum Dis; 2016 Dec; 75(12):2108-2113. PubMed ID: 27091837
[TBL] [Abstract][Full Text] [Related]
3. Disparity between ultrasound and clinical findings in psoriatic arthritis.
Husic R; Gretler J; Felber A; Graninger WB; Duftner C; Hermann J; Dejaco C
Ann Rheum Dis; 2014 Aug; 73(8):1529-36. PubMed ID: 23740228
[TBL] [Abstract][Full Text] [Related]
4. Residual symptoms and disease burden among patients with psoriatic arthritis: is a new disease activity index required?
Kilic G; Kilic E; Nas K; Kamanlı A; Tekeoglu İ
Rheumatol Int; 2019 Jan; 39(1):73-81. PubMed ID: 30426235
[TBL] [Abstract][Full Text] [Related]
5. Can disease activity in patients with psoriatic arthritis be adequately assessed by a modified Disease Activity index for PSoriatic Arthritis (DAPSA) based on 28 joints?
Michelsen B; Sexton J; Smolen JS; Aletaha D; Krogh NS; van der Heijde D; Kvien TK; Hetland ML
Ann Rheum Dis; 2018 Dec; 77(12):1736-1741. PubMed ID: 30237203
[TBL] [Abstract][Full Text] [Related]
6. Pain Catastrophizing, Subjective Outcomes, and Inflammatory Assessments Including Ultrasound: Results From a Longitudinal Study of Rheumatoid Arthritis Patients.
Hammer HB; Uhlig T; Kvien TK; Lampa J
Arthritis Care Res (Hoboken); 2018 May; 70(5):703-712. PubMed ID: 28805018
[TBL] [Abstract][Full Text] [Related]
7. Fatigue is cross-sectionally not associated with objective assessments of inflammation, but changes in fatigue are associated with changes of disease activity assessments during biologic treatment of patients with established rheumatoid arthritis.
Hammer HB; Michelsen B; Sexton J; Uhlig T; Provan SA
Clin Rheumatol; 2021 May; 40(5):1739-1749. PubMed ID: 33040226
[TBL] [Abstract][Full Text] [Related]
8. Evaluating current definitions of low disease activity in psoriatic arthritis using ultrasound.
Bosch P; Husic R; Ficjan A; Gretler J; Lackner A; Graninger WB; Duftner C; Hermann J; Dejaco C
Rheumatology (Oxford); 2019 Dec; 58(12):2212-2220. PubMed ID: 31199483
[TBL] [Abstract][Full Text] [Related]
9. The association of clinical parameters and ultrasound verified inflammation with patients' and physicians' global assessments in psoriatic arthritis.
Lackner A; Duftner C; Ficjan A; Gretler J; Hermann J; Husic R; Graninger WB; Dejaco C
Semin Arthritis Rheum; 2016 Oct; 46(2):183-189. PubMed ID: 27373500
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Composite Indices Tailored for Psoriatic Arthritis Treated with csDMARD and bDMARD: A Cross-sectional Analysis of a Longitudinal Cohort.
Lubrano E; De Socio A; Perrotta FM
J Rheumatol; 2017 Aug; 44(8):1159-1164. PubMed ID: 28572467
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Disease Activity index for PSoriatic Arthritis (DAPSA) with a quick quantitative C reactive protein assay (Q-DAPSA) in patients with psoriatic arthritis: a prospective multicentre cross-sectional study.
Proft F; Schally J; Brandt HC; Brandt-Juergens J; Burmester GR; Haibel H; Käding H; Karberg K; Lüders S; Muche B; Protopopov M; Rademacher J; Rios Rodriguez V; Torgutalp M; Verba M; Zinke S; Poddubnyy D
RMD Open; 2022 Nov; 8(2):. PubMed ID: 36323487
[TBL] [Abstract][Full Text] [Related]
12. Disease activity and response assessment in psoriatic arthritis using the Disease Activity index for PSoriatic Arthritis (DAPSA). A brief review.
Smolen JS; Schoels M; Aletaha D
Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S48-50. PubMed ID: 26471734
[TBL] [Abstract][Full Text] [Related]
13. Composite Measures of Disease Activity in Psoriatic Arthritis: Comparative Instrument Performance Based on the Efficacy of Guselkumab in an Interventional Phase II Trial.
Helliwell PS; Deodhar A; Gottlieb AB; Boehncke WH; Xu XL; Xu S; Wang Y; Hsia EC; Gladman DD; Ritchlin CT
Arthritis Care Res (Hoboken); 2020 Nov; 72(11):1579-1588. PubMed ID: 31421033
[TBL] [Abstract][Full Text] [Related]
14. Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with rheumatoid arthritis and psoriatic arthritis: data from the prospective multicentre NOR-DMARD study.
Michelsen B; Kristianslund EK; Hammer HB; Fagerli KM; Lie E; Wierød A; Kalstad S; Rødevand E; Krøll F; Haugeberg G; Kvien TK
Ann Rheum Dis; 2017 Apr; 76(4):708-711. PubMed ID: 27707730
[TBL] [Abstract][Full Text] [Related]
15. A proposal on how to assess the weight of the subjective components of the DAPSA in patients with psoriatic arthritis and comorbid fibromyalgia syndrome.
Di Carlo M; Tardella M; Di Matteo A; Beci G; De Angelis R; Salaffi F
Clin Exp Rheumatol; 2020; 38 Suppl 123(1):60-64. PubMed ID: 32116210
[TBL] [Abstract][Full Text] [Related]
16. Need for Improvement in Current Treatment of Psoriatic Arthritis: Study of an Outpatient Clinic Population.
Michelsen B; Diamantopoulos AP; Høiberg HK; Soldal DM; Kavanaugh A; Haugeberg G
J Rheumatol; 2017 Apr; 44(4):431-436. PubMed ID: 28148701
[TBL] [Abstract][Full Text] [Related]
17. Psoriatic arthritis: improvement in outcomes but persistent sex difference - 5-year follow-up study of a Norwegian outpatient clinic population.
Łosińska K; Michelsen B; Kavanaugh A; Korkosz M; Haugeberg G
Scand J Rheumatol; 2024 Jan; 53(1):10-20. PubMed ID: 37656147
[TBL] [Abstract][Full Text] [Related]
18. DAPSA, DAS28 and MDA predict long-term treatment regime in psoriatic arthritis. The Swedish Early Psoriatic Arthritis Cohort.
Lindqvist U; Wernroth ML; Husmark T; Larsson P; Geijer M; Teleman A; Theander E; Alenius GM
Clin Exp Rheumatol; 2017; 35(6):936-942. PubMed ID: 28628468
[TBL] [Abstract][Full Text] [Related]
19. Critical importance of patient-reported outcomes for a comprehensive assessment of psoriatic arthritis patients.
Lo Monaco M; Mallaci Bocchio R; Natoli G; Giardina A; Cangemi I; Scibetta S; Argano C; Corrao S
Front Med (Lausanne); 2023; 10():1332432. PubMed ID: 38293304
[TBL] [Abstract][Full Text] [Related]
20. Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score.
Schoels MM; Aletaha D; Alasti F; Smolen JS
Ann Rheum Dis; 2016 May; 75(5):811-8. PubMed ID: 26269398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
